Progressive Supranuclear Palsy (PSP) Terminated Phase 3 Trials for Rasagiline (DB01367)

Also known as: Progressive Supranuclear Palsy / Steele-Richardson-Olszewski syndrome / Supranuclear Palsy, Progressive

IndicationStatusPhase
DBCOND0063930 (Progressive Supranuclear Palsy (PSP))Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01187888Efficacy, Tolerability and Safety of Azilect in Subjects With Progressive Supranuclear PalsyTreatment